Microtest (3285), a digital multimedia and LCD module manufacturer, achieved a record monthly consolidated revenue of NT$175 million in October 2026, marking the highest single-month performance in over 10 years. The figure represented a 131% month-over-month increase and a 212% year-over-year surge, both ranking as the second-largest growth rates since at least 2013. For the first 10 months of 2026, consolidated revenue reached NT$999 million, up 87% year-over-year and setting an 8-year high. The company attributed the revenue growth to increased sales of medical products and PCB drilling equipment compared to 2025.
Microtest Achieves Record NT$175 Million Revenue in October 2026
Microtest reported October 2026 consolidated revenue of NT$175 million, the company's first monthly record in over a decade. The month-over-month growth rate of 131% and year-over-year increase of 212% both marked the second-strongest expansion since at least 2013. Cumulative revenue for the first 10 months of 2026 totaled NT$999 million, representing an 87% year-over-year increase and the highest 10-month figure in eight years.
Q1-Q3 2026 Financial Results Show 364% Net Profit Growth
Microtest released its financial report on November 12, showing consolidated revenue of NT$825 million for the first three quarters of 2026, up 72% year-over-year. Operating gross profit reached NT$214 million, a 95% increase, while operating profit climbed to NT$75.34 million, representing an 11.5-fold year-over-year gain. Pre-tax net profit stood at NT$86.05 million, up 353%, and net profit attributable to shareholders totaled NT$64.6 million, a 364% increase. Earnings per share for the period reached NT$1.51, compared to NT$0.32 in the same period of the previous year and NT$0.70 for the full year 2025.
Medical Products and PCB Drilling Equipment Drive Revenue Expansion
The company stated that increased sales volumes of medical products and PCB drilling equipment accounted for the overall revenue growth compared to 2025. These two product categories served as the primary drivers behind the year-over-year revenue expansion across all reported periods.
Analysts Project 2026 EPS May Challenge 2010 Record
Market analysts noted that the revenue surge from medical products and PCB drilling equipment positions Microtest for strong full-year performance. Analysts stated that the company's full-year 2026 earnings per share may exceed NT$2 and potentially challenge the historical record of NT$2.17 set in 2010.
FAQ
What revenue did Microtest achieve in October 2026?
Microtest reported consolidated revenue of NT$175 million in October 2026, the highest monthly figure in over 10 years, with a 131% month-over-month increase and 212% year-over-year growth.
What were Microtest's earnings per share for Q1-Q3 2026?
Microtest's earnings per share reached NT$1.51 for the first three quarters of 2026, compared to NT$0.32 in the same period of 2025 and NT$0.70 for the full year 2025.
What products drove Microtest's revenue growth in 2026?
The company attributed the revenue increase to higher sales volumes of medical products and PCB drilling equipment compared to 2025.
